GlobeNewswire Inc.··Inmune Bio Inc.INmune Bio Wins FDA Fast Track for Alzheimer's Drug XPro1595
INmune Bio receives FDA Fast Track designation for XPro1595, a first-in-class TNF inhibitor for early Alzheimer's disease, accelerating development and regulatory review.
INMBprecision medicineFDA Fast Track designation